Overview

Study of Inhaled Glucocorticosteroid Administration in Asthma Patients

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
0
Participant gender:
All
Summary
Once-daily inhaled glucocorticosteroids treatment can sufficiently control airway inflammation in asthma patients.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hamamatsu University
Treatments:
Beclomethasone
Budesonide
Criteria
Inclusion Criteria:

- Receive ICS for one year or more, with no change in dose within the previous 8 weeks

Exclusion Criteria:

- Two or more courses of oral corticosteroid in the previous 12 months

- Admission to hospital due to asthma in the previous 6 months

- Admission to the intensive care unit due to asthma at any time in the past

- Current cigarette smoker.